Healthy Patients
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Healthcare professionals who wish to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Medical Microbiologists, Infectiologists and other specialists
- General Practitioners, Pharmacists
- Infection Prevention Experts and nurses
- Medical Docters and Caretakers in nursing homes
- Managers and Labtechnicians of Microbiological Laboratories.
Latest Topics
-
27 April 2024Navigating antimicrobial resistance in a globalized world: The crucial roles of the gut microbiome and migration
Antimicrobial resistance (AMR) is a global health issue, affecting lifesaving antimicrobials. The human microbiome, a complex ecosystem of microbes, is a significant reservoir of AMR genes. The gut microbiota, a reservoir of ARGs, can be passed between different microbial species, leading to the spread of resistant microbes. Antimicrobial exposure disrupts the gut microbiome’s balance, promoting […]
Read more... -
25 April 2024EU approves new antibiotic to tackle rise of superbugs
The European Commission has approved a new antibiotic, Emblaveo, for serious illnesses like pneumonia and urinary tract infections. Emblaveo, marketed by US pharmaceutical company Pfizer, combines two existing medicines to tackle Gram-negative bacteria, which are among the leading drug-resistance threats. The treatment is likely to be used in a narrow group of serious cases to […]
Read more... -
25 April 2024Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the Coronavirus Disease 2019 Outbreak: An Interrupted Time Series Analysis of 2016–2021 Data
A study analyzing the appropriateness of US outpatient antibiotic prescribing after the COVID-19 outbreak found that the proportion of enrollees with ≥1 inappropriate prescription decreased in March 2020 but increased in December 2021. The study used Optum’s Clinformatics Data Mart Database, a national commercial and Medicare Advantage claims database, to assess the impact of the […]
Read more...
More news related to Healthy patients